Stay updated on Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with links to cc.nih.gov and opm.gov, and updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T10:44:26.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Glossary toggle added and several date-related fields updated (Results First Posted, Certification/Extension First Posted, Last Update Submitted/Posted). A new site revision label (v3.4.0) appears, and previously shown 'Estimated' dates were removed.
    Difference
    0.3%
    Check dated 2026-01-28T06:23:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added '(Estimated)' labels for 'Results First Posted', 'Certification/Extension First Posted', and 'Last Update Posted', and removed the corresponding non-estimated labels.
    Difference
    0.1%
    Check dated 2026-01-21T04:13:51.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A 'Results Posted' section has been added detailing primary and secondary outcomes (IGF-1 response, GH <1.0 ng/mL, and Acromegaly Symptoms Diary) with their timeframes, replacing prior entries such as 'Results Submitted' and older timepoint data.
    Difference
    2%
    Check dated 2026-01-14T01:57:31.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Added a new Locations section with expanded US and international study sites (e.g., California, Maryland, Massachusetts, Pennsylvania, Tennessee, Buenos Aires, Ceará, Paraná, Rio Grande do Sul, Lima region, Kemerovo Oblast, Novosibirsk Oblast, Samara Oblast, Tatarstan Republic, South Yorkshire, West Midlands) and updated the revision to v3.3.3; removed the prior location subsections (California Locations, Maryland Locations, Massachusetts Locations, etc.) and older Revision v3.3.2.
    Difference
    1%
    Check dated 2025-12-23T21:27:12.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing the previous v3.2.0, with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:48:46.000Z thumbnail image

Stay in the know with updates to Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.